麦科罗夫生物制有限公司招聘简章.docVIP

麦科罗夫生物制药招聘简章药有限公司是。McCull Pharma) is a startup global biopharmaceutical company based mainly in US and China. The company is committed to develop and manufacture innovative prescription products that address significant unmet medical needs for the worldwide markets. The company has a research portfolio in the therapeutically areas of oncology, cardiovascular and CNS, and provide high quality products and value-added specialties for the changing world. 美国麦科罗夫公司“世界药谷” 美国新泽西，注册在被誉为“世界跨国公司之都”美国) 的制药界资深人士。麦科拥有创新技术，国际营销渠道，与美欧厂商及药品供应商有广泛联系。 McCull , a Delaware Corporation, was formed in 2005 by a group of professionals from world’s famous pharmaceutical giants such as Merck, Novartis, Sanofi-Aventis，Roche，JJ and AstraZeneca. The US business operation is conveniently located in central New Jersey, the world’s hub of the pharmaceutical industry. 麦科的首要任务是在中国实现制药工业化生产，利用自身的现有成熟技术和国际资源，首先开发生产一些有市场前景/有较高技术壁垒和在中国尚未实现国产化的“重磅炮弹”新药项目。第一阶段的产业化项目以注射剂/粉针剂为主。 McCull develop and manufacture innovative drug products that present one or more competitive barriers to entry, such as difficulty sourcing raw material, complex formulation or special handling requirements. We employ our proprietary processes and formulation skills to develop bioequivalent versions of selected brand name pharmaceuticals primarily predicated upon non-infringement of established brand drugs. 麦科制药核心竞争力在于它真正国际标准的制药管理与创新技术平台。麦科主要管理成员来自美国各大型制药跨国公司和国内大型制药公司具有丰富制药管理经验的资深专家。麦科引入国际先进的管理模式，将麦科纳入与世界接轨的规范体系。 McCull’s core strengths relay on its advanced quality system and US standard GMP manufacture capability as a global player. The key members of the management are from US Big Pharma companies. They were highly trained and have many years’ experiences in the US Pharmaceutical industry. 麦科制剂产品与高端原料药以出口为主，产品市场定位于跨国公司与中国企业之间的利润空间。麦科产品未来在中国市场的主要竞争是在国际市场。麦科第一阶段主要产品为面向美国市场的高端抗凝血McCull’s drug products and API are mainly for meeting the great demands of US and EU markets. Commercially, we are strategically positioning in a niche